PBT down 2.2% while ROE fell to 9.3% on NIM compression

Reported NPAT was essentially flat at NZ$95.9m (+0.8%) because the effective tax rate dropped from 30.6% to 28.5% — without that benefit, the underlying earnings line moved down, not sideways.

Return on equity fell to 9.3% from 11.8% as the post-FY22 capital raise lifted total equity to NZ$1.03bn (+27.4%). Underlying net interest margin compressed 16bps to 4.00% (reported NIM down 8bps to 3.97%), and the underlying impairment expense ratio rose 7bps to 0.36%. The full-year dividend was 11.5cps versus 11.0cps prior, with a final component of 6.0cps. The prior comparable included material acquisition activity that affects clean year-on-year comparability.

1. Heartland is now earning the same dollars of profit on a meaningfully larger capital base, and the FY22 raise has not yet translated into commensurate earnings. For a finance company, ROE is the cleanest single read on whether capital is being deployed productively, and this gap is the central tension in the result.

2. Underlying NIM compressed 16bps while the book grew 10.1%. Volume growth largely offset spread compression to deliver the headline revenue gain, but the trajectory implies funding cost pressure or asset-mix dilution is biting into the core economic engine. If spreads do not stabilise, further book growth alone will not restore PBT direction.

3. Credit quality has drifted, not deteriorated. The underlying impairment expense ratio of 0.36% is small in absolute terms, but a 7bps rise signals the credit cycle has turned. Combined with NIM pressure, it is the more important quality signal than the cash-flow line.

The HY23 interim delivered NPAT of NZ$48.7m, implying H2 NPAT of NZ$47.2m — a slightly softer second half than first, consistent with the underlying NIM trajectory observed during the year.

The release references an outlook section, but the supplied excerpts do not contain specific FY24 NIM, impairment, or ROE expectations. What the release supports is that receivables growth remained robust at 10.1%; what it does not support is a view that the FY24 starting margin or impairment ratio will mirror FY23 averages.

The underlying quality of this result is weaker than the +0.8% NPAT line implies. PBT growth of -2.2% is the cleaner operating read, because the difference is explained almost entirely by a 2.1pp drop in the effective tax rate (28.5% versus 30.6%). For a bank, tax-rate volatility is not a sustainable source of earnings, so the durable trajectory should be assessed off PBT direction.

The operating cash flow swing from -NZ$262m to +NZ$43m is not a meaningful quality indicator for a finance company; it reflects period-on-period changes in lending and funding flows rather than operating earnings durability. The dividend payout has risen to 82.4% of NPAT from 68.2%, increasing the share of earnings being distributed at the same time as ROE is declining and underlying impairments are creeping higher. That combination — softer underlying earnings, lower returns on capital, and a higher payout ratio — leaves less internal cushion if NIM compression continues into FY24.

This briefing cannot assess regulatory capital adequacy, funding mix detail, segment-level NIM contributions, or arrears beyond the headline impairment expense ratio.